The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by munusamy m, 2019-12-19 08:36:11

HAI Book 2020 - Dec 18B

HAI Book 2020 - Dec 18B

Authors Presenter

anseeuw | Jacobs | Schultz | Buckley | Properzi | Hanseeuw,

arrell | Scott | Hampton | Sanchez | Sperling | Johnson Bernard

ansson | Andersson | Janelidze | Ossenkoppele | Insel

trandberg | Zetterberg | Blennow | Chai | Dage | Hansson, Oskar

omrud | Smith | Palmqvist | Mattsson

arada | Lerdsirisuk | Yiqing | Ezura | Shimizu | Harada, Ryuichi
orito | Arai | Yanai | Kudo | Furumoto | Okamura

siao | Lin | Huang | Huang Hsiao, Ing-Tsung

ccarino | La Joie | Lesman-Segev | Soleimani-

eigooni | Provost | Collins | Aisen | Borowski |

oyan | Fagan | Foroud | Gatsonis | Jack Jr. | Kramer | Iaccarino,
aykin | Toga | Vemuri | Day | Graff-Radford | Honig | Leonardo
nes | Masdeu | Mendez | Onyike | Rogalski |

alloway | Wolk | Wingo | Koeppe | Dickerson |

postolova | Carrillo | Rabinovici

ccarino | La Joie | Edwards | Lesman-Segev | Strom | Iaccarino,
ham | Chaudhary | Fenton | Jerome | Janabi | Baker | Leonardo
iller | Jagust | Fagan | Rabinovici

ang | Ottoy | Savard | Pascoal | Mathotaarachchi | Kang, Min Su
enedet | Chamoun | Therriault | Lussier | Tissot |
homas | Stevenson | Rahmouni | Arias | Wang |
assarweh | Soucy | Gauthier | Rosa-Neto

ang | Ottoy | Chamoun | Mathotaarachchi | Savard | Kang, Min Su
enedet | Pascoal | Therriault | Lussier | Tissot |
homas | Stevenson | Rahmouni | Fernandez-Arias |
ang | Massarweh | Soucy | Gauthier | Rosa-Neto

m | Park | Park | Kang | Kim | Jang | Kim | Na | Lee | Kim, Jaeho
eo

ein | Sanabria | Leuzy | Borroni | Mattsson | Klein, Gregory
almqvist | Stomrud | Smith | Hansson

oran | Shams | Adams | Cazevedo | Toueg | Corso | Mormino,
unt | Castillo | Hall | Sha | Fredericks | Greicius | Elizabeth
agner | Zaharchuk | Davidzon | Chin | Mormino

enedet | J. Ashton | A. Pascoal | Stoops | Francois | Benedet, Andrea
anmechelen | K. Karikari | Mathotaarachchi | Savard
Therriault | Chamoun | Zetterberg | Blennow | Rosa-
eto

euzy | Smith | Ossenkoppele | Santillo | Borroni | Leuzy, Antoine
ein | Olsson | Jögi | Palmqvist | Mattsson |
randberg | Stomrud | Hansson

euzy | Klein | Ossenkoppele | Mattsson | Janelidze |
almqvist | Strandberg | Coloma | Borroni | Stomrud | Leuzy, Antoine
mith | Hansson

n | Hsiao | Huang | Huang Lin, Kun-Ju

anser | Sanabria Bohorquez | Teng | Baker | Toth | Manser, Paul
arik | Weimer

argolin | Lin | Tempest | Chen | Marek | Russell | Margolin,
andiego | Huang | Hsiao | Tamagnan | Alagille | Guan Richard
Lu | Zuo | Higuchi | Jang

ecca | Chen | Naganawa | Toyonaga | Godek | Harris
Bartlett | Zhao | Gallezot | Nabulsi | Huang | Arnsten | Mecca, Adam
arson | van Dyck

26

Board Poster Title
#

151 Mental and physical activity during the uptake period Mi
affects off-target binding in extra- and within-brain |B
Tau PET (18F-FTP)

Na

152 In vivo uptake of 18F-PM-PBB3 (18F-APN-1607) in Ta

patients with corticobasal syndrome |H

Zh

153 Factors predicting tau PET status in cognitively Os
unimpaired and impaired individuals Ma
Ha

Widespread amyloid is necessary to detect tau-PET

154 signal beyond the entorhinal crtex and cognitive Oz

decline

Using 18F-Flortaucipir visual assessment to define T- Pro

155 status in the AT(N) framework: evaluation of intra- Seg

and inter-rater reliability Jan

Defining T-status in the AT(N) framework: Pro
156 comparison of 18F-Flortaucipir visual assessment, Se
Ed
SUVR quantification and CSF pTau Jag

Plasma neurofilament light is associated with regional Qu

157 tau tangle burden in autosomal dominant AD: Ve

Findings from the COLBOS Project Ga

Application of tau PET as a biomarker of AD in Sal
158 therapeutic trials: A pharmaceutical industry Co

perspective

159 Measuring increases of tau pathology in AD using Sa
[18F]GTP1 (Genentech tau probe 1) PET imaging Ma

160 Evaluation of tau PET staging in the A4/LEARN San
study Ru
Re

161 Clinical evaluation o[18F]-JNJ-64326067, a candidate Sch
PET tracer for the detection of tau pathology in AD Ba
|K

Association between cerebrospinal fluid neurofilament

162 light chain and markers of neurofibrillary Sch

pathophysiology: Findings from the Knight Alzheimer Go

Disease Research Center

163 18F-PM-PBB3 (18F-APN-1607) uptake associates Sh
with plasma NfL level and motor disability in patients Ta
with progressive supranuclear palsy |N
Ka

164 The rate of accumulation of tau aggregates is higher in Sm

females and younger individuals Os

165 Resting state functional connectivity associations with Sv
F18-Florbetapir PET versus F18-Flortaucipir PET Ris

166 Tau positivity: Comparing flortaucipir meta-ROI vs Th
maximal single region Ka

167 Intrinsic connectivity of the human brain provides Th
scaffold for tau aggregation in AD Be
Ma

168 Changes in volumetric MRI measures at 12 months To
significantly correlate with baseline [18F]GTP1 Ma
SUVR, but not [18F]GTP1 change

Elevated medial temporal lobe Tau PET with 18F- To
169 PI2620 in normal controls with “borderline” Ha
Sh
neuropsychological testing profiles

170 Hippocampal tau accumulation predicts individual Tre
differences in episodic memory in cognitively normal Jay
older adults Da
|C

2

Authors Presenter

in | Apgar | Scott | Hol | Lundt | Albertson | Schwarz Min, Hoon-Ki
Botha | Vemuri | Gunter | Petersen | Jack | Lowe

akano | Shimada | Tagai | Matsuoka | Kubota |
akahata | Takado | Shinotoh | Yamamoto | Sano | Seki Nakano,
Hirano | Ono | Tempest | Jang | Sahara | Kawamura | Yoshikazu
hang | Kuwabara | Higuchi

ssenkoppele | Leuzy | Cho | La Joie | Strandberg | Ossenkoppele, Rik
atsson | Palmqvist | Lyoo | Rabinovici | Smith |
ansson

zlen | Binette | Köbe | Meyer | Villeneuve Ozlen, Hazal

ovost | Iaccarino | Soleimani-Meigooni | Lesman- Provost, Karine
egev | La Joie | Edwards | Strom | Pham | Mellinger | Provost, Karine
nabi | Baker | Jagust | Rabinovici Quiroz, Yakeel

ovost | Iaccarino | Soleimani-Meigooni | Lesman-
egev | La Joie | Mattsson | Hansson | Eichenlaub |
dwards | Strom | Pham | Mellinger | Janabi | Baker |
gust | Rabinovici

uiroz | Zetterberg | Reiman | Sanchez | Guzman-
elez | Fox-Fuller | Arboleda-Velasquez | Baena |
atchel | Sperling | Johnson | Blennow | Lopera

alinas | Lohith | Guo | Wooten | Tulip | Sanjeewa | Salinas, Cristian
omley | Sur | Hostetler | Beaver | Martarello

anabria Bohorquez | Baker | Manser | Toth | Teng | Sanabria
arik | Weimer Bohorquez,
Sandra

anchez | Becker | Jacobs | Hanseeuw | Mayblyum |
ubinstein | Thibault | Schultz | Seshadri | Quiroz | Sanchez, Justin
entz | Price | Sperling | Johnson | the A4 Study Team

chmidt | Janssens | Moechars | Rombouts | Timmers |
arret | Constantinescu | Madonia | Russell | Sandiego Schmidt, Mark
Kolb

chultz | Schindler | Chen | Sutphen | Morris | Fagan | Schultz, Stephanie
ordon | Benzinger

himada | Tagai | Tatebe | Matsuoka | Kubota |

akahata | Takado | Shinotoh | Yamamoto | Sano | Seki Shimada, Hitoshi
Nakano | Ono | Hirano | Tempest | Jang | Sahara |

awamura | Zhang | Tokuda | Higuchi

mith | Mattsson | Pontecorvo | Devous | Strandberg | Smith, Ruben
ssenkoppele | Hansson

valdi | Goñi | Stage | Abbas | Dzemidzic | West | Svaldi, Diana
sacher | Saykin | Apostolova

herneau | Schwarz | Wiste | Gunter | Senjem | Lowe | Therneau, Terry
antarci | Petersen | Knopman | Mielke | Jones | Jack

herriault | Pascoal | Savard | Mathotaarachchi | Therriault, Joseph
enedet | Chamoun | Gauthier | Saha-Chaudhuri |
assarweh | Rosa-Neto

oth | Sanabria Bohorquez | Manser | Baker | Teng | Toth, Balasz
arik | Weimer

oueg | Deutsch | Castillo | Hunt | Corso | Trelle |
arrison | Azevedo | Shen | Anders | Hall | Fredericks | Toueg, Tyler
ha | Davidzon | Chin | Khalighi | Wagner | Mormino

elle | Toueg | Castillo | Channappa | Corso | Hunt |

yakumar | Nadiadwala | Guo | Azevedo | Shin | Trelle, Alexandra
avidson | Deutsch | Hall | Sha | Fredericks | Kerchner

Carr | Chin | Wagner | Mormino

27

Board Poster Title
#

Temporo-limbic tau burden, as measured by 18F- Fis
Bu
171 AV1451, is a correlate of hippocampal volume loss
over time Wi
Be
172 Temporal evaluation for maximum CSF pTau181 – Wo
[18F]Flortaucipir concordance Tim
Bo
173 [18F]flortaucipir PET is more closely associated with Be
disease severity than CSF p-tau in AD
Sh
Associations of tau pathology and functional
174 connectivity with retrospective cognitive change

among cognitively normal older adults

2

Authors Presenter

scher | Ahnen | Dissertori | Lustermann | Weber | Unschuld, Paul
uck | Kagerer | Gietl | Hock | Unschuld

isch | Gordon | Schindler | Flores | Dincer | Fagan | Ances, Beau
enzinger | Morris | Ances Wolters, Emma

olters | Ossenkoppele | Verfaillie | Coomans |
mmers | Visser | Tuncel | Golla | Windhorst |
oellaard | van der Flier | Teunissen | Scheltens | van
erckel

hafer | Bilgel | Ziontz | Wong | Resnick Ziontz, Jacob

28

POSTER INDEX (by presente

Board Poster Title
#

100 Entorhinal tau pathology is associated with medial Ad
temporal lobe hyperactivity in aging Sta

120 Depression is predicted by tau imaging biomarker Ba
among cognitively normal adults Mo

53 Socioeconomic status mediates racial differences seen Wi
using the A-T(N) Framework Flo

172 Temporal evaluation for maximum CSF pTau181 – Wi
[18F]Flortaucipir concordance Be

01 Label-free x-ray method for estimating brain amyloid Ba
load

144 Cerebrospinal fluid tau phosphorylated at amino acid Be
181 or 231: a biomarker comparison in the detection of Va
neurofibrillary tangle pathology in the AD spectrum |T
Ne

02 Examining regional MK-6240 patterns and associations Be
with amyloid and cognitive decline Co
As

03 Transcriptomic profiling of brain amyloidosis using Bh
peripheral blood-based gene expression

121 Local associations between tau and neurodegeneration Bil
among non-demented older adults

04 A pons cluster detected by a data-driven approach may Bis
serve as a favorable reference region for 18F-PI-2620 Per
Tau PET analysis

122 Perfusion-phase 18F-PI-2620 tau-PET imaging as a Bre
surrogate marker of neuronal injury Ma
Ha
Ru
|M
|L
Vil

Bre

| Pa

Binding characteristics of 18F-PI-2620 differentiate the Ba

123 clinically predicted tau isoform in suspected 3/4-repeat Ru

and 4-repeat tauopathies Ma

Le

|D

124 18F-PI2620 tau-PET for assessment of heterogeneous Bre
neuropathology in corticobasal syndrome Hö
Ste
Eim
|L

80 Sex differences in the rates of cognitive decline Bu
associated with temporal lobe FTP-PET signal: findings Ha
from the Harvard Aging Brain Study

125 Optimal reference region for the quantification of tau Bu
load in the brain using 18F-PI-2620 PET San

05 Early detection of amyloid load using 18F-Florbetaben Bu
PET |T
De

Age-related neural dedifferentiation of episodic memory
06 networks is related to beta-amyloid and tau pathology in Ca

normal aging

126 Quantifying tau PET imaging reliably in the presence of Ch
off-target binding Flo
Mo

[18F]THK5317 imaging as a predictive tool of Ch
127 prospective cognitive decline in prodromal and An

dementia-stage AD

2

er’s last name)

Authors Presenter

dams | Maass | Berron | Harrison | Baker | Thomas | Adams, Jenna
anfill | Jagust Ances, Beau
Ances, Beau
abulal | Roe | Stout | Rajasekar | Wisch | Benzinger | Ances, Beau
orris | Ances

isch | Hudson | Coble | Xiong | Babulal | Gordon |
ores | Dincer | Benzinger | Morris | Ances

isch | Gordon | Schindler | Flores | Dincer | Fagan |
enzinger | Morris | Ances

adano | Dahal | Ghammraoui Badano, Aldo

enedet | J. Ashton | A. Pascoal | Stoops | Francois | Benedet, Andrea
anmechelen | K. Karikari | Mathotaarachchi | Savard
Therriault | Chamoun | Zetterberg | Blennow | Rosa-
eto

etthauser | Cody | Koscik | Jonaitis | Erickson |
onverse | Murali | Barnhart | Stone | Mueller | Clark | Betthauser, Tobey
sthana | Christian | Johnson

harthur Sanjay | Svaldi | Apostolova Bharthur Sanjay,
Apoorva

lgel | Wong | Resnick Bilgel, Murat

schof | van Eimeren | Koglin | Müller | Bullich | Bischof, Gerard
errotin | Stephens | Drzezga

endel | Beyer | Nitschmann | Barthel | van Eimeren |
arek | Song | Palleis | Respondek | Sauerbeck |
ammes | Barbe | Onur | Jessen | Saur | Schroeter |
umpf | Rullmann | Schildan | Patt | Neumaier | Barret Brendel, Matthias
Madonia | Russel | Stephens | Roeber | Herms | Bötzel
Levin | Classen | Hoeglinger | Bartenstein |
llemagne | Drzezga | Seibyl | Sabri

endel | Song | Beyer | Barthel | van Eimeren | Marek

alleis | Kaiser | Respondek | Sauerbeck | Hammes |

arbe | Onur | Jessen | Saur | Schroeter | Rumpf |

ullmann | Schildan | Patt | Neumaier | Barret | Brendel, Matthias

adonia | Russel | Stephens | Roeber | Herms | Bötzel |

evin | Classen | Hoeglinger | Bartenstein | Villemagne

Drzezga | Seibyl | Sabri

endel | Palleis | Prix | Gehmeyr | Bötzel | Danek |

öllerhage | Sauerbeck | Beyer | Nitschmann | Song |

ephens | Barthel | Patt | Sabri | Drzezga | van Brendel, Matthias

meren | Villemagne | Bartenstein | Perneczky | Haass

Levin | Hoeglinger

uckley | Properzi | Schultz | Jacobs | Kirn | Rentz | Buckley, Rachel
anseeuw | Johnson | Sperling

ullich | Müller | Roé-Vellvé | Jovalekic | Perrotin | De Bullich Roig,

anti | Koglin | Stephens Santiago

ullich | Roé-Vellvé | Marquié | Villemagne | Sanabria
Tartari | Sotolongo | Doré | Koglin | Müller | Perrotin | Bullich, Santiago
e Santi | Tárraga | Stephens | Rowe | Seibyl | Boada

assady | Adams | Maass | Harrison | Baker | Jagust Cassady, Kaitlin

hen | Gordon | McCullough | Zaza | Mejias | Dincer |

ores | Keefe | Paulick | Jackson | Koudelis | Su | Chen, Charles

orris | Benzinger

hiotis | Savitcheva | Poulakis | Saint-Aubert | Wall | Chiotis,

ntoni | Nordberg Konstantinos

29

Board Poster Title
#

Imaging synaptic and mitochondrial function in Cla
73 frontotemporal dementia using [11C]UCB-J, Sch

[18F]BCPP-EF and [11C]SA4503 PET Co
Cla
105 Longitudinal associations between lifestyle risk, β-
amyloid, and cognition in late-midlife

62 Correlation of QSM signal with Alzheimer’s Disease Co
biomarkers Kn
Ve
Pet

128 Comparison of quantitative cutoff methods for Mi
[18F]AV-1451 Aiz

Co

71 Quantitative regional amyloid burden and white matter Alv

changes in preclinical AD Be

con

Individual variability in the cortical distribution of
70 elevated 18F-AV1451 and 11C-PIB in a heterogeneous Co

sample of AD patients

07 Tau pathology and synaptic loss are closely associated Co
in Alzheimer’s disease in vivo: a combined Os
Sch
[18F]flortaucipir and [11C]UCB-J PET study Be

Longitudinal dynamic [18F]flortaucipir PET reveals Co

08 increased early stage tau pathology in individuals with Tim

subjective cognitive decline Wi

92 Amyloid deposition disrupts functional connectivity and Ing
graph properties within the default mode network Ko
Te

09 Preliminary evaluation of synaptic vesicle protein SV2A DiF
imaging with [11C]UCB-J across the cognitive En
spectrum

93 Neuroinflammation in AD patients and correlates with Ed
amyloid and tau deposition

85 Sex differences in regional tau deposition in cognitively Ed

impaired patients with Alzheimer’s disease Mi

69 Higher microglia biomarker levels are associated with Ew
slower rates of amyloid-beta accumulation in humans Blu
and in a transgenic mouse model of amyloid-beta

Early declines in learning and executive function Far
99 associated with accumulating Aβ not tau in low PIB Ha

adults

Fer

129 Pilot study on the relationship between 18F-MK-6240 Ka
and VBM in early and late stages of AD Tis

Ma

10 Quantifying off-target skull binding in [18F]Flortaucipir Flo

PET studies |H

Influence of iron and beta-amyloid deposition on
11 entorhinal cortex and hippocampal subfield volumes in Fo

the aging brain

130 Functional connectivity brain architecture predicts the Fra
rate of tau accumulation in AD Os

Association of tau tangle burden with depressive Ga
68 symptoms in community dwelling older adults: a Pro
Ch
longitudinal study Ha

78 Amyloid deposition affects the topography of cortical Ye
thinning in Lewy Body Disease Joh

13 Beta-amyloid deposition and its association with Go
metabolism Be

Amyloid binding is associated with markers of white Go

14 matter microstructure in patients with significant white Bo

matter disease La

3

Authors Presenter

arke | Mansur | Passchier | Lewis | Evans | Chen | Clarke, Mica
chwarz | Takano | Gunn | Cash | Rabiner | Rohrer

ody | Koscik | Birdsill | Berman | Erickson | Chin | Cody, Karly
ark | Christian | Betthauser | Johnson

ogswell | Wiste | Senjem | Therneau | Lowe | Cogswell, Petrice
nopman | Botha | Graff-Radford | Jones | Kantarci |
emuri | Ferman | Boeve | Mielke | Schwarz | Gunter |
etersen | Jack

inhas | Laymon | Lopresti | Snitz | Tudorascu | Cohen, Ann
zenstein | Lopez | Mathis | Klunk | Cohen

ollij | Top | Stickney | Ingala | Tomassen | Lopes Collij, Lyduine
ves | Yaqub | Wink | Van 't Ent | Scheltens | Van
erckel | Visser | Barkhof | Den Braber | AMYPAD
nsortium

ollins | Eckbo | McGinnis | Dickerson Collins, Jessica

oomans | Verfaillie | Wolters | Tuncel | Golla | Coomans, Emma
ssenkoppele | Scheper | Schober | Sweeney | Ryan |
chuit | Windhorst | Scheltens | Boellaard | van
erckel

oomans | Visser | Ossenkoppele | Verfaillie | Coomans, Emma
mmers | Wolters | Tuncel | Schmidt | Boellaard |
indhorst | Scheltens | van der Flier | van Berckel

gala | Wink | Prent | van 't Ent | Tomassen | ten Kate | den Braber,
onijnenberg | Collij | Yaqub | Scheltens | de Goes | Anouk
eunissen | Barkhof | van Berckel | Visser | den Braber

Filippo | Murali | McKinney | Davenport | Barnhart | DiFilippo,

ngle | Betthauser | Johnson | Bendlin | Christian Alexandra

dison | Leng | Dani | Brooks Edison, Paul

dwards | La Joie | Iaccarino | Kim | Baker | Casaletto | Edwards, Lauren
iller | Jagust | Rabinovici

wers | Brendel | Suarez-Calvet | Biechele | Sacher | Ewers, Michael
ume | Haass | Franzmeier

arrell | Papp | Buckley | Jacobs | Schultz | Properzi | Farrell, Michelle
anseeuw | Rentz | Johnson | Sperling

ernandez Arias | Pascoal | Benedet | Thierrault | Su Fernandez Arias,
ang | Savard | Ottoy | Mathotaarachchi | Lussier | Jaime
ssot | Thomas | Stevenson | Rahmouni | Wang |
assarweh | Soucy | Gauthier | Rosa-Neto

ores | Gordon | Su | Christensen | Dincer | Adedokun Flores, Shaney
Hornbeck | Morris | Benzinger

oster | Kennedy | Rodrigue Foster, Chris

anzmeier | Neitzel | Rubinski | Smith | Strandberg | Franzmeier,

ssenkoppele | Hansson | Ewers Nicolai

atchel | Marshall | Yang | Donovan | Buckley | Gatchel, Jennifer
operzi | Quiroz | Rabin | Vannini | Amariglio |
hhatwal | Rentz | Blacker | Sperling | Johnson |
anseeuw

e | Touroutoglou | Brickhouse | Katz | Growdon | Gomperts,
hnson | Dickerson | Gomperts Stephen

ordon | Goyal | Couture | Flores | Morris | Raichle | Gordon, Brian
enzinger | Vlassenko

oubran | Ozzoude | Adamo | Zukotynski | Bocti |

orrie | Chertkow | Frayne | Gao | Hsiung | Kiss | Goubran, Maged

aforce | Noseworthy | Prato | Ramirez | Sahlas | Scott

30

Board Poster Title
#

| Sm
So

107 Data-driven approach to characterization of tau Gr
accumulation in Braak staging groups Ap

How innocent is PART?: Mesial temporal tau is Gr
131 associated with worse cognitive performance in Aβ-

negative cognitively normal individuals

15 CSF dynamics explains discrepant PET-CSF AD Gu
biomarkers Ka
Jon
Jac

132 CSF P-tau detects cerebral tau accumulation earlier than Gu
tau PET in amyloid positive elderly adults

Hippocampal volume mediates the relationship between
20 amyloidosis and amyloid-sensitive cognitive composite Kim

in preclinical AD

77 A sensitive composite model to determine subtle Ha
cognitive differences in preclinical Alzheimer’s disease

Defining a Centiloid scale threshold predicting long-

61 term progression to dementia in patients attending the Ha
Memory Clinic: An F18-Flutemetamol amyloid-PET Bu

study

133 Amyloid, tau, and atrophy in preclinical AD: A Ha
longitudinal study Far

134 Increased levels and phosphorylation of soluble tau Ha
proteins occur earlier than changes in Tau PET in AD | St
Sto

135 Preclinical characterization of [18F]THK-5562, a novel Ha

tau PET tracer with little off-target binding Mo

17 [11C]PiB amyloid quantification and choice of He
reference region La

Comparison of tau PET imaging using 18F-APN-1607
136 and 18F-THK5351 in Alzheimer’s disease patients and Hs

normal controls

Retrospective prediction of amyloid accumulation Hw
18 trajectories in a risk-enriched Alzheimer’s disease Sin

cohort with sequential neural network

137 In vivo amyloid-PET and tau-PET evidence in early- Iac
onset AD: taking the LEADS Me
Elo
Sa
Jon
Sal
Ap

Multimodal in vivo investigation of amyloid and tau Iac
138 biomarkers associations with cerebrospinal fluid NfL Ph
Mi
and YKL40 levels

19 Data-driven biological pattern scoring of Flortaucipir Jon
scans outperforms ROIs Jos
Kn

139 Activated microglia and amyloid load potentiate tau Ka
deposition leading to cognitive dysfunction in AD Be
Th
Ma

Ka

140 Tauopathy in females is more vulnerable to amyloid or Be
neuroinflammation in AD Th

Wa

91 Prevalence of amyloid PET positivity in cognitively Kim
normal the East Asian populations

141 Prediction of brain tau accumulation in amyloid positive Kim
cognitive impairment patients using multimodal Seo
biomarkers with machine learning approach

3

Authors Presenter

mith | Sossi | Strother | Swartz | Tardif | Thiel | Groh, Jenna
oucy | Black
roh | Svaldi | Stage | Sanjay | Risacher | Saykin |
postolova

root Groot, Colin

unter | Senjem | Cogswell | Schwarz | Lowe | Gunter, Jeffrey
antarci | Vemuri | Elder | Botha | Graff-Radford |
nes | Mielke | Graff-Radford | Knopman | Petersen |
ck, Jr.

uo | Jagust | Landau Guo, Tengfei

m | Hahn | Kim | Kim | Chin | Seo Hahn, Alice

ahn | Kim | Kim | Jang | Kim | Na | Chin | Seo Hahn, Alice

anseeuw | Malotaux | Dricot | Quenon | Cerman | Hanseeuw,
uckley | Farrar | Ivanoiu | Lhommel Bernard

anseeuw | Jacobs | Schultz | Buckley | Properzi | Hanseeuw,

arrell | Scott | Hampton | Sanchez | Sperling | Johnson Bernard

ansson | Andersson | Janelidze | Ossenkoppele | Insel

trandberg | Zetterberg | Blennow | Chai | Dage | Hansson, Oskar

omrud | Smith | Palmqvist | Mattsson

arada | Lerdsirisuk | Yiqing | Ezura | Shimizu | Harada, Ryuichi
orito | Arai | Yanai | Kudo | Furumoto | Okamura

eeman | Hendriks | van Berckel | Lopes Alves | Heeman, Fiona
ammertsma | Yaqub

siao | Lin | Huang | Huang Hsiao, Ing-Tsung

wang | Koscik | Betthauser | Tao | Kim | Johnson | Hwang, Seong Jae
ngh

ccarino | La Joie | Lesman-Segev | Soleimani-

eigooni | Provost | Collins | Aisen | Borowski |

oyan | Fagan | Foroud | Gatsonis | Jack Jr. | Kramer | Iaccarino,
aykin | Toga | Vemuri | Day | Graff-Radford | Honig | Leonardo
nes | Masdeu | Mendez | Onyike | Rogalski |

alloway | Wolk | Wingo | Koeppe | Dickerson |

postolova | Carrillo | Rabinovici

ccarino | La Joie | Edwards | Lesman-Segev | Strom | Iaccarino,
ham | Chaudhary | Fenton | Jerome | Janabi | Baker | Leonardo
iller | Jagust | Fagan | Rabinovici

nes | Graff-Radford | Botha | Senjem | Wiste | Jones, David
sephs | Whitwell | Kantarci | Boeve | Petersen |
nopman | Lowe | Jack

ang | Ottoy | Savard | Pascoal | Mathotaarachchi | Kang, Min Su
enedet | Chamoun | Therriault | Lussier | Tissot |
homas | Stevenson | Rahmouni | Arias | Wang |
assarweh | Soucy | Gauthier | Rosa-Neto

ang | Ottoy | Chamoun | Mathotaarachchi | Savard | Kang, Min Su
enedet | Pascoal | Therriault | Lussier | Tissot |
homas | Stevenson | Rahmouni | Fernandez-Arias |
ang | Massarweh | Soucy | Gauthier | Rosa-Neto

m | Jung | Na | Kim | Won | Seo Kim, Jaeho

m | Park | Park | Kang | Kim | Jang | Kim | Na | Lee | Kim, Jaeho
eo

31

Board Poster Title
#

Kim

74 First-in-human evaluations of [11C]PS13 for imaging | Si
COX-1 and [11C]MC1 for imaging COX-2 Mo

Pik

21 Concordance of visual and quantitative assessments of Kle
baseline amyloid scans in the GRADUATE Ba
gantenerumab studies

142 Comparison of longitudinal change metrics for 18F- Kle
RO948 PET among cognitively unimpaired and patients Pal
with MCI or AD dementia in the BioFINDER2 study

64 Evaluating the relationships among odor identification, Kle
tau pathology and neuroinflammation in Alzheimer’s Ho

disease

22 Regional amyloid burden is associated with higher Ko
quantitative T1 in discrete hippocampal sub-regions |C

23 Genetically informed quantitative Gradient Recalled Ko
Echo MRI reveals brain tissue in hippocampal subfields Fag
void of neurons in mild Alzheimer's disease

24 Validation of highly sensitive and specific florbetaben La
positivity thresholds using ADNI participants and young Ko
controls

Voxel-wise relationships between white matter Ga

12 hyperintensities (WMH) and multimodal neuroimaging Go

biomarkers of Alzheimer’s disease La

25 Additive contribution of white matter hyperintensity to La
amyloid and neurodegeneration on cognitive decline in a Ste
diverse, community-based cohort of older adults

26 White matter hyperintensities are related to tau burden La

in late-Braak stage regions Lu

27 Probability template method for analysis of Down La
Syndrome amyloid PET Tu

67 Distinct effects of APOE ε2 on Aβ in Alzheimer- and Le
vascular-type cognitive impairment Os
Kim

28 Visualizing brain astrocytes - characterization of 3H- Le
BU99008 in human AD brain tissue

Diagnostic performance of [18F]RO948 tau positron Le

145 emission tomography in the differentiation of AD from Kle

other neurodegenerative disorders Str

146 Longitudinal changes in tau pathology measured by Le
[18F]RO948 tau-PET are associated with elevated CSF Pal
P-tau: Preliminary findings from the Swedish Sm
BioFINDER-2 study

Application of an epidemic spreading model to Le

29 characterize amyloid beta accumulation in autosomal
dominant Alzheimer’s disease mutation carriers

A comparison of ischemic stroke-induced changes on Lin
147 18F-APN-1607 (18F-PMPBB3) and 18F-THK-5351

uptake patterns

Phantom-based harmonization of PET image
30 reconstruction parameters between the Siemens ECAT Lo

HR+ PET and the GE Discovery MI PET/CT scanners

Longitudinal change in amyloid load over a 5-year Lu
79 period in cognitively healthy APOE4 carriers versus La

non-carriers: Effect of reference region

113 Mild behavioral impairment is associated with tau Lu
pathology in cognitively impaired elderly individuals |M
Ga

Modeling the trajectory of tau deposition in autosomal- Lu

114 dominant AD using the high-affinity tau tracer Ma

[18F]MK6240 Ne

101 Clinicopathological confirmation of 123I-FP-CIT Ma
SPECT (ioflupane) quantification methods in a Mi

3

Authors Presenter

m | Juarez Anaya | Lee | Hong | Miller | Telu | Morse

ingh | Cortes-Salva | Henry | Ruiz-Perdomo | Kim, Min-Jeong
ontero Santamaria | Liow | Zoghbi | Fujita | Katz |

ke | Innis

ein | Delmar | Voyle | Hesterman | Petrulli | Ovens | Klein, Gregory
audler | Fontoura | Doody | Kerchner

ein | Sanabria | Leuzy | Borroni | Mattsson | Klein, Gregory
almqvist | Stomrud | Smith | Hansson

ein | Yan | Johnson | Tomljanovic | Zou | Polly | Klein, Julia
onig | Brickman | Stern | Lee | Kreisl

ohli | Yang | Vogt | Asthana | Betthauser | Alexander Kohli, Akshay
Christian | Johnson | Kecskemeti | Bendlin

othapalli | Benzinger | Aschenbrenner | Goyal | Kothapalli, Satya
agan | Raichle | Morris | Yablonskiy V.V.N.

andau | Korman | Bullich | De Santi | Stephens | Landau, Susan
oeppe | Jagust

aubert | Lange | Garnier-Crussard | Bougacha | Lange, Catharina
onneaud | de Flores | Tomadesso | Mézenge |
andeau | de La Sayette | Chételat | Wirth

ao | Chesebro | Colon | Igwe | Gu | Schupf | Manly | Lao, Patrick
ern | Mayeux | Brickman

ao | Laing | Igwe | Chesebro | Kreisl | Moreno | Lao, Patrick
uchsinger | Brickman Laymon, Charles
Lee, Jin San
aymon | Minhas | James | Christian | Cohen | Klunk |
udorascu | Royse | Zaman | Handen

ee | Lee | Park | Choe | Park | Cheon | Hahn |
ssenkoppele | Kim | Kim | Yoo | Jang | Cho | Kim |
m | Jung | Park | DeCarli | Weiner | Yun | Na | Seo

emoine | Malarte | Koistinen | Nordberg Lemoine, Laetitia

euzy | Smith | Ossenkoppele | Santillo | Borroni | Leuzy, Antoine
ein | Olsson | Jögi | Palmqvist | Mattsson |
randberg | Stomrud | Hansson

euzy | Klein | Ossenkoppele | Mattsson | Janelidze |
almqvist | Strandberg | Coloma | Borroni | Stomrud | Leuzy, Antoine
mith | Hansson

evitis | Vogel | Kiar | Funck | Iturria-Medina | Evans Levitis, Elizabeth

n | Hsiao | Huang | Huang Lin, Kun-Ju

ois | Grogg | El Fakri | Johnson | Price Lois, Cristina

uckett | Adamczuk | Schaeverbeke | Gabel | Van Luckett, Emma
aere | Dupont | Vandenberghe

ussier | Pascoal | Therriault | Tissot | Savard | Benedet
Mathotaarachchi | Stevenson | Ismail | Rosa-Neto | Lussier, Firoza
authier

ussier | Therriault | Pascoal | Savard |
athotaarachchi | Robb | Stevenson | Gauthier | Rosa- Lussier, Firoza
eto

altais | Jordan | Miyagawa | Lesnick | Przybelski | Maltais, Daniela
in | Dickson | Murray | Kantarci | Boeve | Lowe

32

Board Poster Title
#

spectrum of neurodegenerative syndromes and
associated pathologies

38 Amyloid PET variability due to variation in MRI Pal
protocol and anatomical segmentation

39 The impact of automatic Tau PET processing on uptake Pal
variability and power analysis in AD

148 Longitudinal change in [18F]GTP1 SUVR over 18 Ma
months depends on baseline SUVR intensity and spatial Ma
distribution and shows trends with cognitive decline

149 18F-APN-1607: a promising PET tracer for multiple Ma
tauopathies San
|L

31 Age prediction and amyloid deposition in SuperAgers Ma
Par

106 Exploring relationships between tau burden and naming Ma

in the aphasic variant of AD Me

32 PiB tracer delivery decreases overtime in preclinical AD Ma
– impact for amyloid pathology measurement Ru
Joh

65 Elevated soluble phosphorylated tau is a marker of early Be

amyloid PiB PET abnormalities and accumulation Fag

A clinically-relevant scheme for qualitatively rating tau

112 PET, amyloid PET, and MRI in neurodegenerative Mc

cognitive presentations

Entorhinal cortical tau accumulation is inversely Me
150 associated with hippocampal synaptic density in older |B
Ca
individuals with normal cognition and early AD

66 Cerebrospinal fluid and PET measures of tau pathology Me
may indicate different stages of AD pathological Vil
progression

Use of the plasma amyloid-beta 42/40 ratio for Mi
96 predicting amyloid PET in a community-based Kn

population

151 Mental and physical activity during the uptake period Mi
affects off-target binding in extra- and within-brain Tau |B
PET (18F-FTP)

34 Sex-specific differences in [18F]AV-1451 off-target Mi
retention Aiz

35 Polygenic risk for Cerebrospinal Fluid (CSF) amyloid Mo
predicts brain amyloid in clinically normal older adults Ma

Cerebrospinal fluid matrix metalloproteinases are

111 associated with compromised white matter Mo
microstructure among older adults: the Vanderbilt |B

memory & aging project

143 Validation of clinical protocols for clinicians analyzing Ko
18F-PI-2620 tau PET/MRI images Hu
Wa

152 In vivo uptake of 18F-PM-PBB3 (18F-APN-1607) in Na
patients with corticobasal syndrome Ta
|H
Zh

94 Development of new alpha7 nicotinic receptor ASEM No
analogs for PET imaging Mi


36 Association between cerebral amyloid accumulation and OD
synaptic density in Alzheimer’s disease: A multitracer Ba
Na
PET study Ca

108 Associations between AD biomarkers and cognition Oh
among cognitively normal older adults

153 Factors predicting tau PET status in cognitively Os
unimpaired and impaired individuals Ma
Ha

3

Authors Presenter

alombit | Manber | Joules | Wolz Manber, Richard

alombit | Manber | Joules | Wolz Manber, Richard

anser | Sanabria Bohorquez | Teng | Baker | Toth | Manser, Paul
arik | Weimer

argolin | Lin | Tempest | Chen | Marek | Russell | Margolin,
andiego | Huang | Hsiao | Tamagnan | Alagille | Guan Richard
Lu | Zuo | Higuchi | Jang

artersteck | Besson | Sridhar | Makowski-Woidan | Martersteck,
arrish | Katsaggelos | Mesulam | Bandt | Rogalski Adam

artersteck | Sridhar | Coventry | Eldes | Wood | Kim | Martersteck,

esulam | Rogalski Adam

ayblyum | Becker | Schultz | Farrell | Jacobs | Mayblyum,
ubinstein | Sanchez | Thibault | Sperling | Price | Danielle
hnson | Hanseeuw

enzinger | Benzinger | Joseph-Mathurin | Benzinger | McDade, Eric
agan | Xiong | Barthélemy | Bateman

cGinnis | Collins | Eckbo | Brickhouse | Dickerson McGinnis, Scott

ecca | Chen | Naganawa | Toyonaga | Godek | Harris
Bartlett | Zhao | Gallezot | Nabulsi | Huang | Arnsten | Mecca, Adam
arson | van Dyck

eyer | Pichet Binette | Gonneaud | Breitner | Meyer, Pierre-
lleneuve Francois

ielke | Algeciras-Schimnich | Campbell | Syrjanen | Mielke, Michelle
nopman | Jack Jr. | Peterson

in | Apgar | Scott | Hol | Lundt | Albertson | Schwarz Min, Hoon-Ki
Botha | Vemuri | Gunter | Petersen | Jack | Lowe

inhas | Yu | Laymon | Lopresti | Snitz | Tudorascu | Minhas, Davneet
zenstein | Lopez | Mathis | Klunk | Cohen Moore, Annah

oore | Dumitrescu | Schultz | Raghavan | Johnson |
ayeux | Sperling | Hohman | Mormino

oore | Pechman | Acosta | Bell | Anderson | Landman Moore, Elizabeth
Blennow | Zetterberg | Gifford | Hohman | Jefferson

oran | Shams | Adams | Cazevedo | Toueg | Corso | Mormino,
unt | Castillo | Hall | Sha | Fredericks | Greicius | Elizabeth
agner | Zaharchuk | Davidzon | Chin | Mormino

akano | Shimada | Tagai | Matsuoka | Kubota |
akahata | Takado | Shinotoh | Yamamoto | Sano | Seki Nakano,
Hirano | Ono | Tempest | Jang | Sahara | Kawamura | Yoshikazu
hang | Kuwabara | Higuchi

ordberg | Lemoine | Mohan | Kuang | Nag | Jia |
iranda Azpiazu | Datta | Arakawa | Varnäs | Ågren | Nordberg, Agneta
ångström | Halldin

Dell | Mecca | Chen | Godek | Harris | Bartlett | O’Dell, Ryan
anks | Kominek | Zhao | Naganawa | Toyonaga | Lu |
abulsi | Vander Wyk | Varma | Arnsten | Huang |
arson | van Dyck

h | Correia | Salloway Oh, Hwamee

ssenkoppele | Leuzy | Cho | La Joie | Strandberg | Ossenkoppele, Rik
atsson | Palmqvist | Lyoo | Rabinovici | Smith |
ansson

33

Board Poster Title
#

A clinically applicable proxy for gold standard Ott

37 quantification of amyloid-beta in Alzheimer’s disease: Hs

Bolus plus constant infusion 18F-AV45 PET | So

154 Widespread amyloid is necessary to detect tau-PET Oz
signal beyond the entorhinal crtex and cognitive decline

[11C]MK-6884 PET tracer for M4 muscarinic Pas
75 cholinergic receptors in AD: Comparison with Wa
Ma
[18F]FDG PET

81 Amyloid and tau PET burden are associated with white Pic
matter bundle abnormalities in asymptomatic De
individuals at risk of AD

Using 18F-Flortaucipir visual assessment to define T- Pro

155 status in the AT(N) framework: evaluation of intra- and Seg

inter-rater reliability Jan

156 Defining T-status in the AT(N) framework: comparison Pro
of 18F-Flortaucipir visual assessment, SUVR Seg
quantification and CSF pTau Ed
Jag

Plasma neurofilament light is associated with regional Qu

157 tau tangle burden in autosomal dominant AD: Findings Ve

from the COLBOS Project Ga

MIND MAPS: Assessment of the mitochondrial - Ra
Pag
40 endoplasmic reticulum - synaptic axis in Mi
neurodegeneration by [18F]BCPP-EF, [11C]SA4503 Ma
Pas
and [11C]UCB-J PET imaging

Ra

41 Associations between Neurogranin and imaging Kv
biomarkers of Alzheimer’s disease Ste

Ga

42 Linking APOE ε4, blood-brain barrier dysfunction and Rip

inflammation to Alzheimer’s pathology Ve

Increased risk of AD in alcohol use disorder is not Ro
104 mediated by amyloid-beta in a middle-aged cross- Na

sectional cohort

43 Heterogeneity of tau PET signal in the sub-nuclei of the Ru
amygdala Ma
Go

Cross-sectional and longitudinal non-dichotomized
86 CSF/PET Aβ data support existence of “CSF+ first” vs. Sal

“PET+ first” pathways of Aβ biomarkers changes

158 Application of tau PET as a biomarker of AD in Sal

therapeutic trials: A pharmaceutical industry perspective Co

82 NeuroToolkit CSF biomarkers track the progression of Sal
AD at very early stages and show that inflammatory Ze
markers modulate cerebral amyloid accumulation Far
Su

Fal

83 T1rho MRI measurement of amyloid plaque burden in Pu
cognitively unimpaired individuals: preliminary results Fer
in the ALFA+ cohort Ro
Mi

Gis

84 Preliminary quantitative results of the AMYPAD Gis
prognostic and natural history study He
Ve
| th

159 Measuring increases of tau pathology in AD using San
[18F]GTP1 (Genentech tau probe 1) PET imaging Ma

San
160 Evaluation of tau PET staging in the A4/LEARN study Ru

Re

3

Authors Presenter

toy | Kang | Verhaeghe | Stroobants | Bouhachi |
siao | Stevenson | Rahmouni | Chartrand | Massarweh Ottoy, Julie
oucy | Gauthier | Rosa-Neto | Staelens

zlen | Binette | Köbe | Meyer | Villeneuve Ozlen, Hazal

ascual | Zanotti-Fregonara | Yu | Funk | Arbones | Pascual, Belen
ang | Li | Cheng | Anderson | Hostetler | Basile |
asdeu

chet Binette | Theaud | Gonneaud | Poirier | Pichet Binette,
escoteaux | Villeneuve Alexa

ovost | Iaccarino | Soleimani-Meigooni | Lesman- Provost, Karine
egev | La Joie | Edwards | Strom | Pham | Mellinger | Provost, Karine
nabi | Baker | Jagust | Rabinovici Quiroz, Yakeel

ovost | Iaccarino | Soleimani-Meigooni | Lesman- Rabiner, Eugenii
egev | La Joie | Mattsson | Hansson | Eichenlaub |
dwards | Strom | Pham | Mellinger | Janabi | Baker | Rahmouni,
gust | Rabinovici Nesrine
Riphagen, Joost
uiroz | Zetterberg | Reiman | Sanchez | Guzman-
elez | Fox-Fuller | Arboleda-Velasquez | Baena |
atchel | Sperling | Johnson | Blennow | Lopera

abiner | Mansur | Venkataraman | Price | Wilson |
agano | Clarke | Lewis | Matthews | Rowe | Brooks |
iddleton | Politis | Rohrer | Comley | Evans |
artarello | Chen | Schwarz | Schmidt | Tsukada |
asschier | Gunn | Consortium

ahmouni | Benedet | Nicholas | Tissot | Pascoal |
vartsberg | Chamoun | Kang | Lussier | Therriault |
evenson | Savard | Mathotaarachchi | Thomas |
authier | Zetterberg | Blennow | Rosa-Neto

phagen | Ramakers | Freeze | Pagen | Hanseeuw |
erbeek | Verhey | Jacobs

oyse | Himes | Minhas | Lopresti | Flanigan | Royse, Sarah
arendran

ubinstein | Jacobs | Augustinack | Properzi | Becker |
ayblyum | Thibault | Sanchez | Schultz | Hanseeuw | Rubinstein, Zoe
omez-Isla | Lois-Gomez | Price | Sperling | Johnson

ala | Nordberg | Rodriguez-Vieitez Sala, Arianna

alinas | Lohith | Guo | Wooten | Tulip | Sanjeewa | Salinas, Cristian
omley | Sur | Hostetler | Beaver | Martarello

alvadó | Molinuevo | Milà-Alomà | Blennow |

etterberg | Operto | Falcón | Batrla | Battle | Buckley | Salvadó, Gemma
arrar | Minguillon | Fauria | Sánchez-Benavides |

uárez-Calvet | Gispert | the ALFA study

alcón | Montesinos | Grau-Rivera | Suárez-Calvet | Salvadó, Gemma
uig-Pijoan | Cascales | Navalpotro-Gomez |
ernández-Lebrero | Sánchez-Valle | Gelpi | Sanfeliu |
ojas | Perissinotti | Niñerola-Baizán | Salvadó |
inguillon | Fauria | Molinuevo | Sánchez-González |
spert | the ALFA study

spert | Lopes-Alves | Gray | Buckley | Collij | Salvadó, Gemma
eeman | Salvadó | Scheltens | Frisoni | Ritchie |
ellas | Stephens | Ford | Molinuevo | Farrar | Barkhof
he AMYPAD Consortium

anabria Bohorquez | Baker | Manser | Toth | Teng | Sanabria
arik | Weimer Bohorquez,
Sandra

anchez | Becker | Jacobs | Hanseeuw | Mayblyum |
ubinstein | Thibault | Schultz | Seshadri | Quiroz | Sanchez, Justin
entz | Price | Sperling | Johnson | the A4 Study Team

34

Board Poster Title
#

72 Effect of genetic risk, brain amyloid and hippocampal Sch
volume on normal variation in episodic memory Du
performance in middle-aged and older adults

161 Clinical evaluation o[18F]-JNJ-64326067, a candidate Sch
PET tracer for the detection of tau pathology in AD Ba
|K

Association between cerebrospinal fluid neurofilament

162 light chain and markers of neurofibrillary Sch
pathophysiology: Findings from the Knight Alzheimer Go

Disease Research Center

44 MCI patients demonstrate reliably increasing 18F- Sco
AV1451 PET uptake across three exams

White matter disruption is an early and progressive Sco
103 feature of pre-symptomatic Dutch-type hereditary |B
Ch
cerebral amyloid angiopathy

Development of a qualitative read method for Sei
45 characterizing the presence and extent of brain tau Ma

deposition using [18F]MK-6240 PET imaging

Head-to-head comparison of F-Florbetaben and F-
88 Flutemetamol uptakes in the cortex, striatum and white Seo

matter

163 18F-PM-PBB3 (18F-APN-1607) uptake associates with Sh
plasma NfL level and motor disability in patients with Ta
progressive supranuclear palsy |N
Ka

16 Predicting future amyloid spread with machine learning Ha
using longitudinal [C11]PiB-PET in preclinical Ch
Alzheimer's disease

164 The rate of accumulation of tau aggregates is higher in Sm
females and younger individuals Os

46 PET imaging of [11C]MPC-6827, a microtoubule-based So
PET tracer in murine models of AD

47 Quantifying the relationship between the brain So
distributions of tau and local atrophy to inter-regional Ka
connectivity based on individual human data

PI-2620 Tau PET is associated with amyloid-beta levels Ste

90 in scans from subjects of the elenbecestat MissionAD Ad

program Alb

48 Monitoring disease pathophysiology using Ste
multiparametric PET acquisitions: The McGill TRIAD Ma
Cohort |L
Sb

165 Resting state functional connectivity associations with Sv
F18-Florbetapir PET versus F18-Flortaucipir PET Ris

110 Using famous faces to investigate the neural systems Te
involved in name retrieval

109 In vivo association of mitochondrial dysfunction with Te
tau pathology in early AD Ne

166 Tau positivity: Comparing flortaucipir meta-ROI vs Th
maximal single region Ka

167 Intrinsic connectivity of the human brain provides Th
scaffold for tau aggregation in AD Be
Ma

Preliminary results: PiB and MK6240 regional PET Ma
102 measures associated with digitized clock drawing |R
Joh
performance

49 Interaction between amyloid and neuroinflammation on Tis
apathy along the Alzheimer’s disease spectrum Ch
Ma

50 Neuropsychiatric symptoms in cognitively impaired Tis
individuals are correlated with tau deposition Sav
Ne

3

Authors Presenter

chaeverbeke | Gabel | Adamczuk | Van Laere | Schaeverbeke,
upont | Vandenberghe Jolien

chmidt | Janssens | Moechars | Rombouts | Timmers |
arret | Constantinescu | Madonia | Russell | Sandiego Schmidt, Mark
Kolb

chultz | Schindler | Chen | Sutphen | Morris | Fagan | Schultz, Stephanie
ordon | Benzinger

cott | Adamczuk | Gorman | Runkle | Suhy Scott, David

cott | Schultz | Sohrabi | Gardener | Taddei | Bateman
Benzinger | Johnson | Sperling | Martins | Greenberg | Scott, Matthew
hhatwal | Investigators

eibyl | Salinas | Rajagovindan | Hutchison | Beaver | Seibyl, John
artarello

eo | Cho | Moon | Choe | Na Seo, Sang Won

himada | Tagai | Tatebe | Matsuoka | Kubota |

akahata | Takado | Shinotoh | Yamamoto | Sano | Seki Shimada, Hitoshi
Nakano | Ono | Hirano | Tempest | Jang | Sahara |

awamura | Zhang | Tokuda | Higuchi

ao | Vogt | Meng | Hwang | Koscik | Betthauser | Singh, Vikas
hristian | Johnson | Bendlin | Singh

mith | Mattsson | Pontecorvo | Devous | Strandberg | Smith, Ruben
ssenkoppele | Hansson

olingapuram sai | Macauley | Whitlow | Mintz | Craft Solingapuram Sai,
Kiran Kumar

oucy | Mohammadi | Rosa-Neto | Pascoal | Savard | Soucy, Jean-Paul
ang | Therriault | Benali

ephens | Bullich | Mueller | Berndt | De Santi | Scott |
damczuk | Suhy | Kaplow | Giroux | Krause | Chang | Stephens, Andrew
bala

evenson | Chamoun | Pascoal | Benedet | Kang |

athotaarachchi | Therriault | Thomas | Savard | Tissot Stevenson, Jenna
Lussier | Vinet-Celluci | Rahmouni | Gagné | Joung |

beiti | Shin | Vitali | Gauthier | Rosa-Neto

valdi | Goñi | Stage | Abbas | Dzemidzic | West | Svaldi, Diana
sacher | Saykin | Apostolova

ennant | Jagust | La Joie | Adams | Winer Tennant, Victoria

erada | Therriault | Min Su | Savard | Ouchi | Rosa- Terada, Tatsuhiro
eto

herneau | Schwarz | Wiste | Gunter | Senjem | Lowe | Therneau, Terry
antarci | Petersen | Knopman | Mielke | Jones | Jack

herriault | Pascoal | Savard | Mathotaarachchi | Therriault, Joseph
enedet | Chamoun | Gauthier | Saha-Chaudhuri |
assarweh | Rosa-Neto

ayblyum | Thibault | Moody | Farrell | Jiang | Jacobs
Rubinstein | Sanchez | Katz | Sperling | Papp | Rentz | Thibault, Emma
hnson

ssot | Kang | Benedet | Rahmouni | Pascoal | Tissot, Cécile
hamoun | Therriault | Lussier | Savard |
athotaarachchi | Thomas | Gauthier | Rosa-Neto

ssot | Therriault | Pascoal | Chamoun | Lussier | Tissot, Cécile
avard | Mathotaarachchi | Benedet | Thomas | Rosa-
eto | Gauthier

35

Board Poster Title
#

168 Changes in volumetric MRI measures at 12 months To
significantly correlate with baseline [18F]GTP1 SUVR, Ma
but not [18F]GTP1 change

Elevated medial temporal lobe Tau PET with 18F- To
169 PI2620 in normal controls with “borderline” Ha
Sh
neuropsychological testing profiles

Hippocampal tau accumulation predicts individual Tre
170 differences in episodic memory in cognitively normal Jay
Da
older adults |C

33 MRI and PET data harmonization in a two-site Down Mi
syndrome study | Jo
Ch

97 Associations between longitudinal cognitive measures Tu
and cross-sectional tau in adults with Down syndrome Ell
Ch

171 Temporo-limbic tau burden, as measured by 18F- Fis
AV1451, is a correlate of hippocampal volume loss over Bu
time

60 Longitudinal flortaucipir ([18F]AV-1451) PET uptake Uti
in Semantic Dementia Cla
Jr.

76 Assessing Aβ, tau, and reactive astrocytosis in aging and Vil
AD Ku

Vo

Developing a novel alpha-synuclein (a-syn) positron Jür

63 emission tomography (PET) tracer for the diagnosis of Da
Parkinson’s disease (PD) and other a-synucleinopathies Hli

Vil

51 Association between [18F]NAV4694 PET amyloid-β Wa
measures and fluid biomarkers across the spectrum of |K
Alzheimer's disease

PET beta-amyloid deposition in healthy older adults is

52 associated with decreased lure discrimination on a We

spatial mnemonic similarity task

95 Biological underpinnings of typical and atypical Wh
Alzheimer’s dementia phenotypes Sch
Kn

89 Sleep impairment predicts longitudinal accumulation of Wi
β-amyloid

Tau pathology and relative cerebral blood flow are Wo

54 independently associated with cognition in Alzheimer’s Tu

disease Fli

173 [18F]flortaucipir PET is more closely associated with Wo
disease severity than CSF p-tau in AD Tim
Bo
Be

87 Personality and amyloid accumulation in cognitively Yo
normal aging

55 Amyloid Load trajectories and chronicity reveal groups Za
of early amyloid accumulators in Down syndrome Co
Ha

56 Hippocampal-retrosplenial cortex connectivity predicts Zio
tau accumulation in cognitively normal older adults

Associations of tau pathology and functional
174 connectivity with retrospective cognitive change among Sh

cognitively normal older adults

Associations of amyloid deposition and FDG uptake in Zu

98 aging and cognitively impaired elders with and without Bo

moderate to severe periventricular white matter No

hyperintensities So

3

Authors Presenter

oth | Sanabria Bohorquez | Manser | Baker | Teng | Toth, Balasz
arik | Weimer

oueg | Deutsch | Castillo | Hunt | Corso | Trelle |
arrison | Azevedo | Shen | Anders | Hall | Fredericks | Toueg, Tyler
ha | Davidzon | Chin | Khalighi | Wagner | Mormino

elle | Toueg | Castillo | Channappa | Corso | Hunt |

yakumar | Nadiadwala | Guo | Azevedo | Shin | Trelle, Alexandra
avidson | Deutsch | Hall | Sha | Fredericks | Kerchner

Carr | Chin | Wagner | Mormino

inhas | Yang | Muschelli | Laymon | Zammit | Ellison
ohnson | Mathis | Crainiceanu | Klunk | Handen | Tudorascu, Dana
hristian | Cohen | Tudorascu

udorascu | Comer | Zammit | Laymon | Minhas | Tudorascu, Dana
lison | Zaman | Ances | Johnson | Mathis | Klunk |
hristian | Handen | Hartley | Cohen

scher | Ahnen | Dissertori | Lustermann | Weber | Unschuld, Paul
uck | Kagerer | Gietl | Hock | Unschuld

ianski | Whitwell | Martin | Botha | Schwarz | Duffy |
ark | Spychalla | Senjem | Petersen | Knopman | Jack, Utianski, Rene
| Lowe | Josephs

llemagne | Harada | Doré | Furumoto | Mulligan | Villemagne,
udo | Krishnadas | Huang | Yanai | Rowe | Okamura Victor

okali | Molette | Tsika | Ravache | Rodriguez |

rgens | Melo dos Santos | Sandiego | Russell | Gunn |

armency | Piorkowska | Poli | Kroth | Capotosti | Vokali, Efthymia

iva | Sol | Marek | Stöhr | Lowe | Pfeifer | Kosco-

lbois

ang | Pascoal | Therriault | Benedet | Lussier | Savard Wang, Yi-Ting
Kang | Tissot | Gauthier | Rosa-Neto

ebb | Foster | Horn | Kennedy | Rodrigue Webb, Christina

hitwell | Tosakulwong | Graff-Radford | Weigand | Whitwell, Jennifer
chwarz | Senjem | Ertekin-Taner | Jones | Boeve |
nopman | Jack | Petersen | Lowe | Josephs

iner | Mander | Jagust | Walker Winer, Joseph

olters | Visser | Verfaillie | Coomans | Timmers | Wolters, Emma
uncel | Boellaard | Windhorst | Scheltens | van der Wolters, Emma
ier | Ossenkoppele | van Berckel

olters | Ossenkoppele | Verfaillie | Coomans |
mmers | Visser | Tuncel | Golla | Windhorst |
oellaard | van der Flier | Teunissen | Scheltens | van
erckel

oon | Baker | Korman | Tennant | Harrison | Jagust Yoon, Bora

ammit | Koscik | Laymon | Betthauser | Tudorascu | Zammit, Matt
ohen | Minhas | Johnson | Zaman | Mathis | Klunk |
anden | Christian

ontz | Adams | Baker | Jagust Ziontz, Jacob

hafer | Bilgel | Ziontz | Wong | Resnick Ziontz, Jacob

ukotynski | Gaudet | Kuo | Adamo | Goubran | Scott | Zukotynski,
octi | Borrie | Chertkow | Frayne | Hsiung | Laforce | Katherine
oseworthy | Prato | Sahlas | Smith | Sossi | Thiel |
oucy | Tardif | Black

36

HAI 2020 PROGRAM

Wednesday, Ja

7:30 AM Check-in and Breakfast
8:15 AM Introductions/Welcome Notes

8:30 AM DIDACTIC SESSION A: PET Technical/Meth

8:30 AM Multi-site and longitudinal studies considerations
8:55 AM Centiloids
9:20 AM Computational lead discovery for radioligands
9:45 AM POSTER SESSION 1A and Coffee Break

10:30 AM DIDACTIC SESSION B: Neuropathology

10:30 AM Basic neuropathology of Abeta, tau and a-syn
11:00 AM Technical considerations for IHC, HC, biochemis
11:30 AM Technical considerations for homogenate binding
12:00 PM Maturity states of plaques and tangles
12:30 PM Lunch

1:45 PM SESSION 1: TECHNICAL I

1:45 PM Evaluation of 18F-JNJ-067 as a tau tracer

2:00 PM A direct comparison of tau imaging agents [F-18]
1451 AND [F-18]MK-6240 in human subjects
2:15 PM A multi-center comparison of [18F]flortaucipir,
[18F]RO948 and [18F]MK6240 tau-PET tracers
2:30 PM optimal target ROIs for differential diagnosis
2:45 PM
3:15 PM Capturing extra-cerebral MK-6240 signal with su
3:45 PM projections
4:00 PM
Discussion Session 1
Keynote Lecture
Keynote Discussion

POSTER SESSION 1B and Coffee Break

4:45 PM SESSION 2: TECHNICAL II

4:45 PM Amyloid Load predicts elevated tau deposition in
syndrome
5:00 PM
TauIQ demonstrates increased power for cross-se
5:15 PM and longitudinal analysis of Tau tracers as eviden
[18F]Flortaucipir and [18F]GTP1
5:30 PM
Spatiotemporal imaging phenotypes of tau pathol
5:45 PM Alzheimer’s disease
6:00 PM
6:30 PM Predicting structural, metabolic and pathologic di
progression in autosomal dominant Alzheimer’s d
with machine learning

Correction of partial volume effects for tau PET i
using the kernel method

Discussion Session 2

Welcome Reception

3

anuary 15, 2020

hods Keith Johnson, MD, Massachusetts General Hospital
s CHAIR: Chester Mathis, PhD, University of
Pittsburgh
Robert Koeppe, PhD, University of Michigan
Christopher Rowe, MD, Austin Health
Robert Mach, PhD, University of Pennsylvania

CHAIR: William Klunk, MD, University of
Pittsburgh
Julie Schneider, MD, Rush University
stry Milos Ikonomovic, MD, University of Pittsburgh
g Laetitia Lemoine, PhD, Karolinska Institute
Melissa Murray, PhD, Mayo Clinic

]AV- CHAIRS:
Brad Christian, PhD, University of Wisconsin-
Madison
Ansel Hillmer, PhD, Yale University
Suzanne Baker, PhD, Lawrence Berkeley National
Laboratory

Brian Lopresti, MS, University of Pittsburgh

to detect Rik Ossenkoppele, PhD, VU University Medical
Center

urface Justin Sanchez, BA, Massachusetts General Hospital

Alan Evans, PhD, McGill University

n Down CHAIRS:
Julie Price, PhD, Harvard Medical School
Suzanne Baker, PhD, Lawrence Berkeley National
Laboratory

Matt Zammit, MS, University of Wisconsin

ectional
nced by Roger Gunn, PhD, Invicro

logy in Jacob Vogel, PhD (cand.), McGill University

isease
disease Patrick Luckett, PhD (cand.), KU Leuven/UZ Leuven

imaging Kuang Gong, PhD, MGH/Harvard Medical School

37

Thursday, Jan

7:30 AM Check-in and Breakfast

8:30 AM SESSION 3:
NEUROPATHOLOGY I

Flortaucipir PET often shows uptake greater in re

8:30 AM outside of the medial temporal lobe than in entorh

in low Braak tangle stage participants

8:45 AM Brain volume and [18F]flortaucipir PET analysis
progressive supranuclear palsy clinical variants

Comparison of autoradiographic binding profiles

9:00 AM Flortaucipir, MK-6240 and PI-2620 in human pos

tissue samples across the spectrum of neurodeg. d

9:15 AM Biochemical correlates of tau and amyloid PET im
four autopsy brains

9:30 AM Discussion Session 3

10:00 AM Keynote Lecture

10:30 AM Keynote Discussion

10:45 AM POSTER SESSION 2A and Coffee Break

11:30 AM SESSION 4:
NEUROPATHOLOGY II

11:30 AM Derivation and potential utility of an Abeta-PET b
accumulation index for estimation of brain Abeta

11:45 AM In vitro study of the evidence of tauopathy in PD
a tau PET tracer, [3H]MK-6240, by autoradiograp

12:00 PM In vitro characterization of second-generation tau
in human autopsy brain tissue

12:15 PM Neurofibrillary tangle maturity: a comprehensive

12:30 PM Discussion Session 4

1:00-2:30 Lunch

2:30 PM SESSION 5:
CLINICAL I

2:30 PM History of head injury is associated with greater t
2:45 PM on [18F]Flortaucipir PET in MCI and AD patient

3:00 PM In vivo measurement of widespread synaptic loss
Alzheimer’s disease with SV2A PET
3:15 PM Amyloid PET is more than just positive or negati
3:30 PM amyloid level impacts risk of clinical progression
4:00 PM demented individuals

18F-PI2620 tau-PET in Progressive Supranuclear
multi-center evaluation

Discussion Session 5

POSTER SESSION 2B and Coffee Break

4:45 PM SESSION 6:
CLINICAL II

4:45 PM Tau-PET associations with amyloid positivity and
impairment
5:00 PM Locus coeruleus integrity tracks with initial Alzhe
disease-related pathology and cognitive decline
5:15 PM Area 35 is the earliest subregion in the medial tem
5:30 PM affected by tau pathology
6:00 PM Discussion Session 6

Networking Reception

3

nuary 16, 2020

egions CHAIRS:
hinal cortex Laetitia Lemoine, PhD, Karolinska Institute
Teresa Gomez-Isla, Mass. General Hospital

Val Lowe, MD, Mayo Clinic

s of Jennifer Whitwell, PhD, Mayo Clinic

of Cinthya Aguero, MD, Massachusetts General
stmortem Hospital
diseases
maging in Milos Ikonomovic, MD, University of
Pittsburgh

Julie Schneider, MD, MS, Rush University

CHAIRS:
Melissa Murray, PhD, Mayo Clinic
Julie Schneider, MD, MS, Rush University

based path. Ruben Smith, MD, PhD, Lund University
a load

brains using Zhizhen Zeng, MD, PhD, Merck & Co. Inc.
phy

u pet tracers Mona-Lisa Malarte, PhD (cand.), Karolinska
Institute

e review Christina Moloney, PhD, Mayo Clinic

CHAIRS:
Keith Johnson, MD, Mass. General Hospital
Pedro Rosa-Neto MD, PhD, McGill University

tau deposition Shannon Risacher, PhD, Indiana University
ts School of Medicine

s in early Adam Mecca, MD, PhD, Yale University

ive: Aβ- Christopher Rowe, MD, Austin Health
n in non-

r Palsy: a Matthias Brendel, MD, University Hospital of
Munich

d cognitive CHAIRS:
eimer's William Jagust, MD, U of California, Berkeley
mporal lobe David Wolk, MD, University of Pennsylvania
Susan Landau, PhD, University of California,
Berkeley
Heidi Jacobs, PhD, Massachusetts General
Hospital

David Berron, PhD, Lund University

38

Friday, Jan

7:30 AM Check-in and Continental Breakfast

8:30 AM SESSION 7: TAU I

8:30 AM The implications of different approaches to define
8:45 AM Alzheimer's disease
9:00 AM
9:15 AM Towards a CenTauR cortical mask
Tau Positivity: Comparing Flortaucipir Meta-RO
Maximum of Regional Z-Scores
POSTER SESSION 3A and Coffee Break

10:00 AM SESSION 7: TAU II

10:00 AM Critical threshold of elevated amyloid associated
tau accumulation: a ca-tau-strophe in the making

10:15 AM The Meaning of Tau Positivity with Respect to C
Progression

10:30 AM Longitudinal tau PET changes in cognitively unim
persons with different β-amyloid levels

10:45 AM Defining a tau positive flortaucipir PET signal rel
neuropathology

11:00 AM Discussion Session 7 (TAU I and TAU II)

12:00 PM Keynote Lecture

12:30 PM Keynote Discussion

12:45 PM Lunch

2:00 PM SESSION 8: CLINICAL III

2:00 PM Glucose metabolism reflects local atrophy and tau
at symptomatic stages of Alzheimer's disease
2:15 PM Plasma FLT1 predicts amyloid-β related cognitiv
cognitively normal older adults
2:30 PM
2:45 PM Reducing sample sizes to detect longitudinal amy
3:15 PM accumulation
4:00 PM
Discussion Session 8

POSTER SESSION 3B and Coffee Break

Awards Ceremony

4:15 PM SESSION 9: PLASMA

4:15 PM Plasma P-tau181 as a marker of tau pathology in
disease: relationship to Tau PET, differential diag
4:30 PM neuropathology and longitudinal progression

4:45 PM Plasma levels of an N-terminal tau fragment are h
5:00 PM associated with future cognitive decline and
5:15 PM neurodegeneration in clinically normal elderly: Fi
the Harvard Aging Brain Study

Plasma biomarkers associate with amyloid and ta
binding in cognitively unimpaired older adults wi
history of AD

High-performance plasma phospho-tau181 bioma
Alzheimer’s disease

Discussion Session 9

5:45 PM Closing Notes

3

nuary 17, 2020

e AT(N) in CHAIRS:
Tobey Betthauser, PhD, University of Wisconsin
Sylvia Villeneuve, PhD, McGill University

Antoine Leuzy, PhD, Lund University

OI vs. Vincent Dore, PhD, CSIRO
Christopher Schwarz, MD, Mayo Clinic

with rapid CHAIRS:
Clinical Clifford Jack, MD, Mayo Clinic
Reisa Sperling, MD, Brigham and Women's
Hospital
Victor Villemagne, MD, Austin Health
Keith Johnson, MD, Massachusetts General
Hospital

Michael Devous, PhD, Avid Pharmaceuticals

mpaired David Knopman, MD, Mayo Clinic

lative to AD Michael Pontecorvo, PhD, Avid Pharmaceuticals

Li-Huei Tsai, PhD, MIT

u pathology CHAIRS:
ve decline in Elizabeth Mormino, PhD, Stanford University
yloid Susan Landau, PhD, UC, Berkeley
Amelia Strom, BS, University of California San
Francisco
Hyun-Sik Yang, MD, Brigham and Women's
Hospital

Isadora Lopes Alves, PhD, VUmc

CHAIR:

Gil Rabinovici, MD, UCSF

Alzheimer’s

gnosis, Oskar Hansson, PhD, Lund University

highly
Jasmeer Chhatwal, MD, MGH/Harvard

indings from University

au PET
ith a parental Pierre-Francois Meyer, PhD, McGill University

arker for Tharick Pascoal, PhD, McGill University

Keith Johnson, MD, Massachusetts General
Hospital

39

HAI 2020 ABSTRACTS

Wednesday, January 15, 2020 - 9:45am - 10:30am

P1A: POSTER SESSION

Board Poster Title
#

53 Socioeconomic status mediates racial differences Wisch | H
seen using the A-T(N) Framework Flores | D

01 Label-free x-ray method for estimating brain Badano
amyloid load
Betthaus
02 Examining regional MK-6240 patterns and Convers
associations with amyloid and cognitive decline | Asthana

03 Transcriptomic profiling of brain amyloidosis Bharthur
using peripheral blood-based gene expression

04 A pons cluster detected by a data-driven approach Bischof
may serve as a favorable reference region for 18F- Perrotin
PI-2620 Tau PET analysis

05 Early detection of amyloid load using 18F- Bullich |
Florbetaben PET Sanabria
| Perrotin
Seibyl | B

Age-related neural dedifferentiation of episodic
06 memory networks is related to beta-amyloid and Cassady

tau pathology in normal aging

Tau pathology and synaptic loss are closely Cooman

07 associated in Alzheimer’s disease in vivo: a Ossenko

combined [18F]flortaucipir and [11C]UCB-J PET Schuit | W

study Berckel

Longitudinal dynamic [18F]flortaucipir PET Cooman
08 reveals increased early stage tau pathology in Timmers
Windhor
individuals with subjective cognitive decline

09 Preliminary evaluation of synaptic vesicle protein DiFilipp
SV2A imaging with [11C]UCB-J across the | Engle |
cognitive spectrum

10 Quantifying off-target skull binding in Flores | G
[18F]Flortaucipir PET studies Adedoku

Influence of iron and beta-amyloid deposition on

11 entorhinal cortex and hippocampal subfield Foster | K

volumes in the aging brain

13 Beta-amyloid deposition and its association with Gordon
metabolism Benzing

Amyloid binding is associated with markers of Goubran
14 white matter microstructure in patients with Borrie | C
Laforce
significant white matter disease Scott | S
| Soucy |

Gunter |

15 CSF dynamics explains discrepant PET-CSF AD Kantarci

biomarkers Jones | M

Jack, Jr.

Hippocampal volume mediates the relationship Kim | Ha
20 between amyloidosis and amyloid-sensitive

cognitive composite in preclinical AD

17 [11C]PiB amyloid quantification and choice of Heeman
reference region Lammer

4

N 1A

Authors Presenter Page

Hudson | Coble | Xiong | Babulal | Gordon | Ances, Beau 154
Dincer | Benzinger | Morris | Ances

| Dahal | Ghammraoui Badano, Aldo 43
44
ser | Cody | Koscik | Jonaitis | Erickson | Betthauser, 47
se | Murali | Barnhart | Stone | Mueller | Clark Tobey
a | Christian | Johnson

r Sanjay | Svaldi | Apostolova Bharthur
Sanjay,
Apoorva

| van Eimeren | Koglin | Müller | Bullich | Bischof, 50
| Stephens | Drzezga Gerard

| Roé-Vellvé | Marquié | Villemagne | 57
a | Tartari | Sotolongo | Doré | Koglin | Müller Bullich,
n | De Santi | Tárraga | Stephens | Rowe | Santiago
Boada

y | Adams | Maass | Harrison | Baker | Jagust Cassady, 52
Kaitlin

ns | Verfaillie | Wolters | Tuncel | Golla |

oppele | Scheper | Schober | Sweeney | Ryan | Coomans, 54

Windhorst | Scheltens | Boellaard | van Emma

ns | Visser | Ossenkoppele | Verfaillie | Coomans, 58
s | Wolters | Tuncel | Schmidt | Boellaard | Emma 61
rst | Scheltens | van der Flier | van Berckel 62

po | Murali | McKinney | Davenport | Barnhart DiFilippo,
Betthauser | Johnson | Bendlin | Christian Alexandra

Gordon | Su | Christensen | Dincer | Flores, Shaney
un | Hornbeck | Morris | Benzinger

Kennedy | Rodrigue Foster, Chris 65

| Goyal | Couture | Flores | Morris | Raichle | Gordon, Brian 68
ger | Vlassenko 70
73
n | Ozzoude | Adamo | Zukotynski | Bocti |

Chertkow | Frayne | Gao | Hsiung | Kiss | Goubran,
| Noseworthy | Prato | Ramirez | Sahlas | Maged
Smith | Sossi | Strother | Swartz | Tardif | Thiel

| Black

Senjem | Cogswell | Schwarz | Lowe |
i | Vemuri | Elder | Botha | Graff-Radford | Gunter,
Mielke | Graff-Radford | Knopman | Petersen | Jeffrey

ahn | Kim | Kim | Chin | Seo Hahn, Alice 88

n | Hendriks | van Berckel | Lopes Alves | Heeman, Fiona 80
rtsma | Yaqub

40

Board Poster Title
#

18 Retrospective prediction of amyloid accumulation Hwang |
trajectories in a risk-enriched Alzheimer’s disease Singh

cohort with sequential neural network

19 Data-driven biological pattern scoring of Jones | G
Flortaucipir scans outperforms ROIs Josephs
Knopma

Concordance of visual and quantitative Klein | D
21 assessments of baseline amyloid scans in the Baudler

GRADUATE gantenerumab studies

Regional amyloid burden is associated with higher Kohli | Y

22 quantitative T1 in discrete hippocampal sub- Alexand

regions Bendlin

Genetically informed quantitative Gradient

23 Recalled Echo MRI reveals brain tissue in Kothapa
hippocampal subfields void of neurons in mild Fagan | R

Alzheimer's disease

Validation of highly sensitive and specific Landau |
24 florbetaben positivity thresholds using ADNI Koeppe

participants and young controls

Voxel-wise relationships between white matter Gaubert

12 hyperintensities (WMH) and multimodal Gonneau

neuroimaging biomarkers of Alzheimer’s disease Landeau

Additive contribution of white matter

25 hyperintensity to amyloid and neurodegeneration Lao | Ch

on cognitive decline in a diverse, community- Stern | M

based cohort of older adults

26 White matter hyperintensities are related to tau Lao | La
burden in late-Braak stage regions Luchsing

27 Probability template method for analysis of Down Laymon

Syndrome amyloid PET Tudorasc

28 Visualizing brain astrocytes - characterization of Lemoine
3H-BU99008 in human AD brain tissue

Application of an epidemic spreading model to

29 characterize amyloid beta accumulation in Levitis |
autosomal dominant Alzheimer’s disease mutation

carriers

Phantom-based harmonization of PET image

30 reconstruction parameters between the Siemens Lois | Gr
ECAT HR+ PET and the GE Discovery MI

PET/CT scanners

38 Amyloid PET variability due to variation in MRI Palombi
protocol and anatomical segmentation

39 The impact of automatic Tau PET processing on Palombi
uptake variability and power analysis in AD

31 Age prediction and amyloid deposition in Marterst
SuperAgers Parrish |

PiB tracer delivery decreases overtime in Mayblyu
32 preclinical AD – impact for amyloid pathology Rubinste
Johnson
measurement

34 Sex-specific differences in [18F]AV-1451 off- Minhas |
target retention Aizenste

Polygenic risk for Cerebrospinal Fluid (CSF) Moore |
35 amyloid predicts brain amyloid in clinically Mayeux

normal older adults

36 Association between cerebral amyloid O Dell |
accumulation and synaptic density in Alzheimer’s Banks | K
| Nabulsi
disease: A multitracer PET study Carson |

37 A clinically applicable proxy for gold standard Ottoy | K
quantification of amyloid-beta in Alzheimer’s Hsiao | S
Massarw
disease: Bolus plus constant infusion 18F-AV45

PET

4

Authors Presenter Page

| Koscik | Betthauser | Tao | Kim | Johnson | Hwang, Seong 82
Jae 85
89
Graff-Radford | Botha | Senjem | Wiste | Jones, David 90
| Whitwell | Kantarci | Boeve | Petersen |
an | Lowe | Jack

Delmar | Voyle | Hesterman | Petrulli | Ovens | Klein, Gregory
| Fontoura | Doody | Kerchner

Yang | Vogt | Asthana | Betthauser | Kohli, Akshay
der | Christian | Johnson | Kecskemeti |

alli | Benzinger | Aschenbrenner | Goyal | Kothapalli, 93
Raichle | Morris | Yablonskiy Satya V.V.N.

| Korman | Bullich | De Santi | Stephens | Landau, Susan 94
| Jagust
Lange, 66
| Lange | Garnier-Crussard | Bougacha | Catharina
ud | de Flores | Tomadesso | Mézenge |
u | de La Sayette | Chételat | Wirth

hesebro | Colon | Igwe | Gu | Schupf | Manly | Lao, Patrick 97
Mayeux | Brickman

aing | Igwe | Chesebro | Kreisl | Moreno | Lao, Patrick 98
ger | Brickman 100
102
n | Minhas | James | Christian | Cohen | Klunk | Laymon,

cu | Royse | Zaman | Handen Charles

e | Malarte | Koistinen | Nordberg Lemoine,
Laetitia

Vogel | Kiar | Funck | Iturria-Medina | Evans Levitis, 103
Elizabeth

rogg | El Fakri | Johnson | Price Lois, Cristina 106

it | Manber | Joules | Wolz Manber, 124
Richard 126
108
it | Manber | Joules | Wolz Manber, 109
Richard 115
117
teck | Besson | Sridhar | Makowski-Woidan | Martersteck,
Katsaggelos | Mesulam | Bandt | Rogalski Adam 120

um | Becker | Schultz | Farrell | Jacobs | Mayblyum, 121
ein | Sanchez | Thibault | Sperling | Price | Danielle
| Hanseeuw

| Yu | Laymon | Lopresti | Snitz | Tudorascu | Minhas,

ein | Lopez | Mathis | Klunk | Cohen Davneet

Dumitrescu | Schultz | Raghavan | Johnson | Moore, Annah
| Sperling | Hohman | Mormino

Mecca | Chen | Godek | Harris | Bartlett | O Dell, Ryan
Kominek | Zhao | Naganawa | Toyonaga | Lu
i | Vander Wyk | Varma | Arnsten | Huang |
van Dyck

Kang | Verhaeghe | Stroobants | Bouhachi |

Stevenson | Rahmouni | Chartrand | Ottoy, Julie

weh | Soucy | Gauthier | Rosa-Neto | Staelens

41

Board Poster Title
#

40 MIND MAPS: Assessment of the mitochondrial - Rabiner
endoplasmic reticulum - synaptic axis in Pagano |
neurodegeneration by [18F]BCPP-EF, Middleto
[11C]SA4503 and [11C]UCB-J PET imaging Martarel
Passchie

Rahmou

41 Associations between Neurogranin and imaging Kvartsbe
biomarkers of Alzheimer’s disease Stevenso

Gauthier

42 Linking APOE ε4, blood-brain barrier dysfunction Riphage

and inflammation to Alzheimer’s pathology Verbeek

43 Heterogeneity of tau PET signal in the sub-nuclei Rubinste
of the amygdala Mayblyu
Gomez-I

44 MCI patients demonstrate reliably increasing 18F- Scott | A
AV1451 PET uptake across three exams

45 Development of a qualitative read method for Seibyl | S
characterizing the presence and extent of brain tau Martarel
deposition using [18F]MK-6240 PET imaging

Predicting future amyloid spread with machine Hao | Vo
16 learning using longitudinal [C11]PiB-PET in Christian

preclinical Alzheimer's disease

46 PET imaging of [11C]MPC-6827, a microtoubule- Solingap

based PET tracer in murine models of AD Craft

Quantifying the relationship between the brain

47 distributions of tau and local atrophy to inter- Soucy | M

regional connectivity based on individual human Kang | T

data

Monitoring disease pathophysiology using Stevenso
48 multiparametric PET acquisitions: The McGill Mathota
Tissot | L
TRIAD Cohort Joung | S

Interaction between amyloid and Tissot | K
Chamou
49 neuroinflammation on apathy along the Mathota
Alzheimer’s disease spectrum

Neuropsychiatric symptoms in cognitively Tissot | T
50 impaired individuals are correlated with tau Savard |
Neto | G
deposition

33 MRI and PET data harmonization in a two-site Minhas |
Down syndrome study Ellison |
Handen

51 Association between [18F]NAV4694 PET Wang | P
amyloid-β measures and fluid biomarkers across Savard |

the spectrum of Alzheimer's disease

PET beta-amyloid deposition in healthy older

52 adults is associated with decreased lure Webb | F
discrimination on a spatial mnemonic similarity

task

Tau pathology and relative cerebral blood flow are Wolters

54 independently associated with cognition in Tuncel |
Alzheimer’s disease Flier | O

Amyloid Load trajectories and chronicity reveal Zammit

55 groups of early amyloid accumulators in Down Cohen |

syndrome Handen

Hippocampal-retrosplenial cortex connectivity Ziontz |
56 predicts tau accumulation in cognitively normal

older adults

4

Authors Presenter Page

| Mansur | Venkataraman | Price | Wilson |

| Clarke | Lewis | Matthews | Rowe | Brooks | Rabiner, 127
on | Politis | Rohrer | Comley | Evans | Eugenii
llo | Chen | Schwarz | Schmidt | Tsukada | 131
133
er | Gunn | Consortium 136

uni | Benedet | Nicholas | Tissot | Pascoal | Rahmouni,
erg | Chamoun | Kang | Lussier | Therriault | Nesrine
on | Savard | Mathotaarachchi | Thomas |
r | Zetterberg | Blennow | Rosa-Neto

en | Ramakers | Freeze | Pagen | Hanseeuw | Riphagen,

k | Verhey | Jacobs Joost

ein | Jacobs | Augustinack | Properzi | Becker | Rubinstein,
um | Thibault | Sanchez | Schultz | Hanseeuw | Zoe
Isla | Lois-Gomez | Price | Sperling | Johnson

Adamczuk | Gorman | Runkle | Suhy Scott, David 140

Salinas | Rajagovindan | Hutchison | Beaver | Seibyl, John 141
llo

ogt | Meng | Hwang | Koscik | Betthauser | Singh, Vikas 76
n | Johnson | Bendlin | Singh
Solingapuram 142
puram sai | Macauley | Whitlow | Mintz | Sai, Kiran
Kumar

Mohammadi | Rosa-Neto | Pascoal | Savard | Soucy, Jean- 143

Therriault | Benali Paul

on | Chamoun | A. Pascoal | Benedet | Kang | Stevenson, 144
aarachchi | Therriault | Thomas | Savard | Jenna 145
Lussier | Vinet-Celluci | Rahmouni | Gagné | 147
Sbeiti | Shin | Vitali | Gauthier | Rosa-Neto 111
149
Kang | Benedet | Rahmouni | Pascoal | Tissot, Cécile
un | Therriault | Lussier | Savard |
aarachchi | Thomas | Gauthier | Rosa-Neto

Therriault | Pascoal | Chamoun | Lussier |
Mathotaarachchi | Benedet | Thomas | Rosa- Tissot, Cécile
Gauthier

| Yang | Muschelli | Laymon | Zammit | Tudorascu,
Johnson | Mathis | Crainiceanu | Klunk | Dana
| Christian | Cohen | Tudorascu

Pascoal | Therriault | Benedet | Lussier | Wang, Yi-Ting
Kang | Tissot | Gauthier | Rosa-Neto

Foster | Horn | Kennedy | Rodrigue Webb, 153
Christina

| Visser | Verfaillie | Coomans | Timmers | Wolters, 157
Boellaard | Windhorst | Scheltens | van der Emma 160
Ossenkoppele | van Berckel
Zammit, Matt
| Koscik | Laymon | Betthauser | Tudorascu |
Minhas | Johnson | Zaman | Mathis | Klunk |
| Christian

Adams | Baker | Jagust Ziontz, Jacob 163

42

Badano, Aldo

P1: Label-free x-ray method for estim

Aldo Badano1, Eshan Dahal1, Bahaa Ghammrao

1FDA, Silver Spring, MD, US
We describe a label-free method based on small-angle
amyloid load in vivo in small-animals and humans. Ou
coherently scattered x rays from amyloid plaques in a
x-ray energies above 30 keV. Using a fixed head ex vi
amyloid load in a mouse head with skull without using
energy polychromatic x rays can be efficiently used in
setting to estimate amyloid load. Furthermore, using M
feasibility of using a photon-counting strip detector an
identify amyloid plaques in a human head phantom. P
simulated to assess the method and determine the radi
power. The result shows the potential of the proposed
quantification of amyloid plaques in the human brain
Keywords: SAXS, x rays, amyloid load

4

mating brain amyloid load

oui1

e x-ray scattering (SAXS) for estimating brain
ur method is based on recording and analyzing the
a mouse or human head at angles smaller than 10◦ with
ivo, we demonstrate the feasibility of estimating
g contrast agent. Using our proposed method, high-
n conjunction with a spectral detector in a pre-clinical
Monte Carlo techniques, we have investigated the
nd high-energy x-ray spectra from 30 to 60 keV to
Phantoms with and without amyloid plaques were
iation dose required to obtain acceptable statistical
d method for accurate in-vivo detection and
with acceptable level of radiation dose.

43

Betthauser, Tobey

P2: Examining regional MK-6240 patt
and cognitive decline

Tobey Betthauser1, Karly Cody1, Rebecca Kosc
Converse1, Dhanabalan Murali1, Todd Barnhart
Clark1, Sanjay Asthana1, Bradley Christian1, Ste

1University of Wisconsin-Madison School of Medicine

Objectives: This work investigated MK-6240 timing
(including extra-axial signal impact), in relation to am
unimpaired sample to identify potential composite reg
Methods: Individuals (N=301, 67±8 years, 273 unimp
the Wisconsin Registry for Alzheimer’s Prevention (W
imaging. 70-90 and 90-110 minute SUVR windows w
(n=236 scans). Inter-regional MK-6240 correlations in
with associations with global PIB DVR in a subset wi
positivity thresholds were compared with z-scores det
effects models assessed associations between longitud
duration, and MK-6240 binding in a WRAP subset, co
Results: MK-6240 increased 3-5% in NFT-associated
90 to 90-110 timeframes, respectively. Compared to P
SUVRs, higher inter-cerebral MK-6240 correlations a
ROIs (Fig.1). Three regional groupings were observed
parietal and frontal; visual cortex). MK-6240 positivit
establish z-scores. Regional MK-6240 z-scores indica
early to advanced Braak NFT stages for increasing lev
three-way interactions between age, estimated PIB(+)
for all three MK-6240 composite regions wherein long
associated with faster rates of PACC-3 decline (Fig.3)
Conclusions: These findings suggest that a medial tem
axial spill-in and is associated with early changes in a

4

terns and associations with amyloid

cik1, Erin Jonaitis1, Claire Erickson1, Alexander
t1, Charles Stone1, Kimberly Mueller1, Lindsay
erling Johnson1

e and Public Health, Madison, USA, Madison, WI, US

parameters and inter-regional binding patterns
myloid burden and cognitive decline in a mostly
gions for tau imaging.

paired, 13 MCI, 7 dementia, 8 under evaluation) from
WRAP) and Wisconsin ADRC underwent MK-6240
were compared in a subset covering 70-110 minutes
nside and outside the brain were investigated along
ith PIB imaging (n=286). Regional MK-6240
termined from either PIB(-) or age<64. Linear mixed-
dinal cognitive decline (PACC-3), estimated PIB(+)
ognitively unimpaired at baseline (n=215).
d regions and 10-15% in extra-axial regions from 70-
PIB(-) cases, PIB(+) cases had higher MK-6240
and lower correlations between brain and extra-axial
d for MK-6240 binding (medial temporal; temporal,
ty thresholds were consistent with PIB(-) or age<64 to
ated stepwise increases in regions associated with
vels of PIB (Fig.2). LME models showed significant
) duration at baseline PACC-3 and MK-6240 SUVR
ger PIB(+) duration and higher MK-6240 were
).
mporal composite ROI for MK-6240 minimizes extra-
amyloid and preclinical cognitive decline.

44

4

45

Keywords: tau, preclinical, decline, amyloid, PET
4

46

Bharthur Sanjay, Apoorva

P3: Transcriptomic profiling of brain
based gene expression

Apoorva Bharthur Sanjay1, Diana Svaldi1, Liana

1Indiana University School of Medicine, Indianapolis,

Objective: In an effort towards pre-symptomatic risk
development in AD, we evaluated the efficacy of char
transcriptomic data with respect to brain amyloidosis.

Methods: We identified 356 ADNI participants who
Florbetapir SUVR, neurodegenerative and CSF measu
AD=34) from same visit. Between-group differential e
transcripts (p<0.001). Pairwise Euclidean distance bet
distance matrix followed by K-means clustering to ide
profile (Fig1). We used cluster-level gene enrichment
process associated with each cluster. Using principal c
component as the “eigen-gene”. The eigen-genes were
amyloid SUVR, hippocampus volume, entorhinal thic
genes that beat the eigen-gene association to amyloid
transcripts identified through our analyses were valida
overlapping data types for association to amyloid SUV

Results: We identified five clusters with distinct over
AD pathogenesis. These were mitochondrial function,
phosphorylation and MAPK activation. All five cluste
SUVR and CSF Abeta measures (p<0.05) (Fig 2). The
amyloid SUVR in the ImaGene dataset.

Demographics table

4

amyloidosis using peripheral blood-

a Apostolova1

, IN, US
assessment, precision medicine and biomarker
racterizing and clustering peripheral blood
.
had corresponding blood gene expression,
ures (Table 1) (CN=120, EMCI=130, LMCI=72 and
expression analyses yielded 864 genes from ~50,000
tween genes was used to construct a gene-gene
entify clusters of genes with similar transcriptomic
t analysis to identify the most relevant biological
component analysis, we assigned the first principal
e used to assess the association of the clusters to
ckness, CSF Abeta and p-tau measures. The top driver
SUVR were identified from each cluster. The
ated in an external dataset (ImaGene) with
VR.
rrepresented biological processes highly relevant in
, protein oligomerization, TGF beta signaling, protein
ers were significantly associated with Florbetapir
e top driver genes showed similar correlation to

47

4

48

Conclusions: Using a data driven approach we found
transcripts which were significantly correlated to amy
blood show promise as non-invasive markers for AD
genes and their metabolic pathways are warranted.
Keywords: blood biomarkers, amyloid burden, genetic

4

d five AD-relevant clusters of peripheral blood RNA
yloid burden. Systems level genetic signatures from
pathology. Further investigations into the driver
c profiling, CSF measures

49

Bischof, Gerard

P4: A pons cluster detected by a data-
favorable reference region for 18F-PI-

Gerard Bischof1, Thilo van Eimeren1,3,4, Norma
Audrey Perrotin5, Andrew Stephens5, Alexande

1Multimodal Neuroimaging Group, Department of Nu
Cologne, Germany
2Department of Neurology, University Hospital Colog
3Department of Neurology, University Hospital Colog
4German Center for Dementia Research (DZNE), Bon
5Life Molecular Imaging GmbH, Berlin, Germany
6Molecular Organization of the Brain, Institute for Ne
Cologne, Germany

One of the current challenges in static tau PET imagin
for count normalization and definition of thresholds fo
disease-related tau pathology. For the available tau-se
cerebellum (e.g., superior cerebellar peduncles, dentat
been reported, rendering the cerebellum as a suboptim
approach may allow to identify regions with negligibl
suitable reference region. Using proportional scaling f
any specific tracer retention can be expected to exhibi
compared to controls. Here, we tested this approach in
negative controls (N=10) who underwent 18F-PI-2620
45-75 minutes p.i., were summed and normalized to th
statistical non-parametric mapping algorithm. A two-s
which regions of the brain elicited relatively lower sig
cluster threshold. The identified clusters were located
stem. These regions were then tested as reference regi
healthy controls and AD patients. The whole mask, pr
followed by the pons cluster (d= 2.5) compared to a ce
underscores the utility of a data-driven approach for id
suggest that a specific pons cluster may show favorab
2620 PET imaging data. Further cross-validation in cl

Keywords: Tau PET, Reference Region, 18F-PI2620,

5

-driven approach may serve as a
-2620 Tau PET analysis

an Koglin5, Andre Müller5, Santiago Bullich5,
er Drzezga1,4

uclear Medicine, University Hospital Cologne,

gne, Cologne, Germany
gne, Cologne, Germany
nn, Germany

euroscience and Medicine (INM-2), Jülich, Germany,

ng is the establishment of a suitable reference region
or consistent identification of individuals with
elective tracers, retention in certain sub-regions of
te nuclei) in both healthy and disease populations has
mal reference region. A hypothesis-free data-driven
le levels of target expression which may serve as a
for group comparison, regions consistently void of
it relatively lower signal in target-positive patients as
n a cohort of AD patients (N=12) and amyloid-
0 imaging and MRI scanning. Dynamic frames from
he individual MRI, skull-stripped and submitted to a
sample t-test using proportional scaling examined
gnal in AD compared to controls with a FWE p<.05
in thalamus, pons, cerebral white matter and brain
ions to examine differences in cortical uptake between
roduced the highest effect size (d= 2.6), closely
erebellar crus region (d= 1.0).Together, this data
dentification of a suitable reference region and
ble properties as a reference region for static 18F-PI-
linically diverse samples may be justified.

static imaging

50

Bullich, Santiago

P5: Early detection of amyloid load us

Santiago Bullich1,2, Núria Roé-Vellvé1,2, Marta
Sanabria3,4,5, Juan Pablo Tartari3,5, Oscar Sotolo
Andre Müller1,2, Audrey Perrotin1,2, Susan De S
Stephens1,2, Christopher C. Rowe6, John P. Seib

1Life Molecular Imaging GmbH, Berlin, Germany
2On behalf of the AMYPAD Consortium, Brussels, Bel
3Fundació ACE Institut Català de Neurociències Apli
Universitat Internacional de Catalunya, Barcelona, S
4Centro de Investigación Biomédica en Red Enfermed
Salud Carlos III, Madrid, Spain
5On behalf of the FACEHBI study group, Barcelona, S
6Departments of Medicine and Molecular Imaging, U
Australia
7Life Molecular Imaging Inc, Boston, MA, US
8Invicro, New Haven, CT, US

Introduction: Pathology-proven 18F-Florbetaben (FB
to discriminate between Alzheimer’s disease patients
(SUVR=1.48 (Sabri et al. 2015)). However, observati
trials focus on the early stages of Aβ deposition. A low
previously developed SUVR cutoffs. The objective of
abnormality cutoff to detect early Aβ deposition and t
Aβ.

Methods: SUVR cutoff was derived from a sample of
2 standard deviation above the mean SUVR. Subseque
studies: (1) Individuals with subjective cognitive decli
(FACEHBI) study) (n=166; 64.9±7.2 y (Rodríguez-G
(MCI) subjects (n=45, 72.69 ± 6.54 y) (Ong et al. 201
using MRI-based regions of interest (reference region
using the standard centiloid (CL) analysis (reference r

Results: Mean SUVRs derived from YHC was 1.16±0
1.02±0.4 (SUVRcutoff=1.09, CLcutoff=12) (CL). Three r
negative subjects (SUVR<1.25), early Aβ accumulatio
deposition (SUVR>1.48). In the test datasets, only sub
0.94±1.6 %/year (MCI)) or “established Aβ pathology
accumulated amyloid in a statistically significant man

Conclusions: An SUVR range from 1.25 to 1.48 is op
subjects that are likely accumulating Aβ.

Keywords: florbetaben, amyloid, SUVR, cutoff

5


Click to View FlipBook Version